YAP-mediated GPER signaling impedes proliferation and survival of prostate epithelium in benign prostatic hyperplasia

• DOI: 10.1016/j.isci.2024.109125
• Publication Date: 2024-02-06T01:32:58Z
• Authors: Zhifu Liu; Senmao Li; Shengbin Chen; Jindong Sheng; Zheng Li; Tianjing Lv; Wei Yu; Yu Fan; Jinlong Wang; Wei Liu; Shuai Hu; Jie Jin
• Keywords: 0301 basic medicine; Cell biology; 03 medical and health sciences; Prostate disease; Molecular biology; Science; Q; Biochemistry; Article

Benign prostatic hyperplasia (BPH) occurs when there is an imbalance between the proliferation and death of prostate cells, which is regulated tightly by estrogen signaling. However, the role of G protein-coupled estrogen receptor (GPER) in prostate cell survival remains ambiguous. In this study, we observed that prostates with epithelial hyperplasia showed increased yes-associated protein 1 (YAP) expression and decreased levels of estrogen and GPER. Blocking YAP through genetic or drug interventions led to reduced proliferation and increased apoptosis in the prostate epithelial cells. Interestingly, GPER agonists produced similar effects. GPER activation enhanced the phosphorylation and degradation of YAP, which was crucial for suppressing cell proliferation and survival. The Gαs/cAMP/PKA/LATS pathway, downstream of GPER, transmitted signals that facilitated YAP inhibition. This study investigated the interaction between GPER and YAP in the prostate epithelial cells and its contribution to BPH development. It lays the groundwork for future research on developing BPH treatments.